晨星:信达生物(01801.HK)- 港股公司研究:减肥药物 Mazdutide 获批及研发管线回顾 - 250630(英文版)(13页).pdf

编号:733708 PDF  中文版  DOCX 13页 446.48KB 下载积分:至尊VIP专享
下载报告请您先登录!

晨星:信达生物(01801.HK)- 港股公司研究:减肥药物 Mazdutide 获批及研发管线回顾 - 250630(英文版)(13页).pdf

1、Morningstar Equity Analyst Note|Report as of 1 Jul 2025 08:20,UTC|Reporting Currency:CNY|Trading Currency:HKD|Exchange:HONG KONG EXCHANGES AND CLEARING LTDPage 1 of 132025 Morningstar.All Rights Reserved.Unless otherwise provided in a separate agreement,you may use this report only in the country in

2、 which its original distributor is based.The information,data,analyses and opinions presented herein do not constitute investment advice;are provided solely for informational purposes and therefore are not an offer to buy or sell a security;and are not warranted to be correct,complete or accurate.Th

3、e opinions expressed are as of the date written and are subject to change without notice.Except as otherwise required by law,Morningstar shall not be responsible for any trading decisions,damages or other losses resulting from,or related to,the information,data,analyses or opinions or their use.The

4、information contained herein is the proprietary property of Morningstar and may not be reproduced,in whole or in part,or used in any manner,without the prior written consent of Morningstar.Investment research is produced and issued by subsidiaries of Morningstar,Inc.including,but not limited to,Morn

5、ingstar Research Services LLC,registered with and governed by the U.S.Securities and Exchange Commission.To order reprints,call+1 312-696-6100.To license the research,call+1 312-696-6869.Please see important disclosures at the end of this report.?Financial Summary and Key Statistics ActualForecast20

6、23202420252026Revenue(CNY Mil)6,2069,42212,01014,466Revenue Growth%36.251.827.520.5Operating Income(Mil)-1,679-756360796Operating Margin%-27.1-8.03.05.5Adjusted EBITDA(Mil)-6954091,2011,664Adjusted EBITDA Margin%-11.24.310.011.5Earnings Per Share(Diluted)(CNY)-0.66-0.060.220.36Adjusted Earnings Per

友情提示

1、下载报告失败解决办法
2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
4、本站报告下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。

本文(晨星:信达生物(01801.HK)- 港股公司研究:减肥药物 Mazdutide 获批及研发管线回顾 - 250630(英文版)(13页).pdf)为本站 (Kelly Street) 主动上传,三个皮匠报告文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知三个皮匠报告文库(点击联系客服),我们立即给予删除!

温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。
客服
商务合作
小程序
服务号
折叠